Product Description
Mechanisms of Action: ADRB2 Agonist,PDE Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: India | Ireland | Italy | Pakistan | Portugal | Russia
Approved Indications: None
Known Adverse Events: None
Company: MEDA Pharma
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: